Joshua Davis

h-index

Research activity per year

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

SDG 3 Good Health and Well-being
SDG 4 Quality Education
SDG 5 Gender Equality
SDG 6 Clean Water and Sanitation
SDG 8 Decent Work and Economic Growth
SDG 10 Reduced Inequalities
SDG 16 Peace, Justice and Strong Institutions

Fingerprint

Dive into the research topics where Joshua Davis is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

8 Finished

Addressing important evidence gaps in the management of severe infectious diseases
Davis, J. (Principal Investigator/Chief Investigator A)
1/01/15 → 31/12/18
Project: Research
A novel Hepatitis B virus genotype in Indigenous Australians: impact on vaccine efficacy and clinical outcomes
Tong, S. Y. C. (Principal Investigator/Chief Investigator A), Locarnini, S. (Co Investigator/Chief Investigator B), Davis, J. (Chief Investigator C), Garvey, G. (Chief Investigator D), Condon, J. (Chief Investigator E), Littlejohn, M. (Chief Investigator F), Wood, N. (Chief Investigator G), Warner, N. (Chief Investigator H) & Walsh, R. (Chief Investigator I)
1/01/14 → 31/12/17
Project: Research
CAMERA: Combination antibiotic treatment for Methicillin Resistant Staphylococcus Aureus Bacteraemia - a Randomised Controlled Trial (CAMERA2)
Davis, J. (Principal Investigator/Chief Investigator A), Tong, S. Y. C. (Co Investigator/Chief Investigator B), Paterson, D. (Chief Investigator C), Fowler Jr, V. (Chief Investigator D), Howden, B. (Chief Investigator E), Cheng, A. (Chief Investigator F), Chatfield, M. (Chief Investigator G), Lipman, J. (Chief Investigator H), van Hale, S. (Chief Investigator I) & O'Sullivan, M. (Chief Investigator J)
1/01/15 → 31/12/19
Project: Research
CAMERA2 - Combination Antibiotic Therapy for Methicillin Resistant Staphylococcus aureus infection. A randomised controlled trial
Davis, J. (Principal Investigator/Chief Investigator A)
1/01/15 → 31/12/16
Project: Research
Determining clinical outcomes associated with different genotypes of Staphylococcus aureus bacteraemia isolates at the Royal Darwin Hospital
Tong, S. Y. C. (Principal Investigator/Chief Investigator A), Davis, J. (Co Investigator/Chief Investigator B), Giffard, P. (Chief Investigator C) & Baird, R. (Chief Investigator D)
1/10/11 → 30/09/12
Project: Research
Hepatitis B in the Top End of the Northern Territory (NT): health literacy among those affected and innovative ways to improve it.
Davis, J. (Principal Investigator/Chief Investigator A), Johnston, V. (Co Investigator/Chief Investigator B) & Davies, J. (Chief Investigator C)
1/02/12 → 31/12/12
Project: Research
Improving outcomes of severe bacterial infections in Northern Australia
Davis, J. (Principal Investigator/Chief Investigator A)
1/01/11 → 31/12/14
Project: Research

168 Article
25 Comment/debate
14 Review article
10 Letter
More

Application of a Novel Desirability of Outcome Ranking Endpoint Incorporating a Framework for Resistance Assessment and Microbiologic Evaluation in Antibiotic Trials: A Proof-of-Concept in a Post Hoc Analysis of the BALANCE Trial
Ong, S. W. X., Patrikar, A., Pinto, R., Mahar, R. K., Rishu, A., Davis, J. S., Fowler, R. A., Tong, S. Y. C. & Daneman, N., Jun 2026, In: Open Forum Infectious Diseases. 13, 6, p. 1-9 9 p., ofag142.
Research output: Contribution to journal › Article › peer-review

Open Access
File
4 Downloads (Pure)
A review of the randomized clinical trial results from the Staphylococcus aureus network adaptive platform (SNAP) meticillin-susceptible (MSSA) and penicillin-susceptible (PSSA) domains and CloCeBa
Goodman, A. L., Easom, N., Bielopolski, D., Sutherland, R. K., Marks, M., Hensgens, M. P. M., Bonten, M., Bostock, J., Walls, G., Lye, D., Boyles, T., Yahav, D., Cheng, M. P., Legg, A., Paul, M., Lescure, F. X., Lee, T. C., Tong, S. Y. C. & Davis, J. S., Jul 2026, In: Journal of Antimicrobial Chemotherapy. 81, 8, p. 1-8 8 p., dkag215.
Research output: Contribution to journal › Review article › peer-review

Open Access
File
1 Downloads (Pure)
Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia
Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Group, Jun 2026, In: The New England journal of medicine. 394, 23, p. 2329-2339 11 p.
Research output: Contribution to journal › Article › peer-review
Comparing different methods for analysing hierarchical composite endpoints: two illustrative case studies with post hoc analyses of the BALANCE (Bacteraemia Antibiotic Length Actually Needed for Clinical Effectiveness) and CAMERA2 (Combination Antibiotics for methicillin-resistant Staphylococcus aureus) randomized clinical trials
Ong, S. W. X., Pinto, R., Mahar, R. K., Petersiel, N., Fowler, R. A., Davis, J. S., Daneman, N., Tong, S. Y. C., Lye, D. C., Yahav, D., Sud, A., Robinson, J. O., Nelson, J., Archuleta, S., Roberts, M. A., Cass, A., Paterson, D. L., Foo, H., Paul, M. & Guy, S. D. & 117 others, Tramontana, A. R., Walls, G. B., McBride, S., Bak, N., Ghosh, N., Rogers, B. A., Ralph, A. P., Davies, J., Ferguson, P. E., Dotel, R., McKew, G. L., Gray, T. J., Holmes, N. E., Smith, S., Warner, M. S., Kalimuddin, S., Young, B. E., Runnegar, N., Andresen, D. N., Anagnostou, N. A., Chatfield, M. D., Cheng, A. C., Fowler, V. G., Howden, B. P., Meagher, N., Price, D. J., van Hal, S. J., Sullivan, M. V. N. O., Rishu, A., Rogers, B. A., Shehabi, Y., Parke, R., Cook, D. J., Arabi, Y., Muscedere, J., Reynolds, S., Hall, R., Dwivedi, D. B., McArthur, C., McGuinness, S., Yahav, D., Geagea, A., Das, P., Shin, P., Detsky, M., Morris, A., Fralick, M., Powis, J., Kandel, C., Sligl, W., Bagshaw, S. M., Singhal, N., Belley-Cote, E., Whitlock, R., Khwaja, K., Morpeth, S., Kazemi, A., Williams, T., MacFadden, D., McIntyre, L., Tsang, J. L. Y., Lamontagne, F., Carignan, A., Marshall, J., Friedrich, J. O., Cirone, R., Downing, M., Graham, C., Duan, E., Neary, J., Evans, G., Alraddadi, B., Aljohani, S., Martin, C., Elsayed, S., Ball, I., Lauzier, F., Turgeon, A. F., Stelfox, H. T., Conly, J., Lee, T. C., McDonald, E. G., Sullivan, R., Grant, J., Kagan, I., Young, P., Lawrence, C., O'Callaghan, K., Eustace, M., Choong, K., Aslanian, P., Buehner, U., Havey, T., Binnie, A., Prazak, J., Reeve, B., Litton, E., Lother, S. A., Kumar, A., Zarychanski, R., Hoffman, T., Paterson, D. L., Daley, P., Commons, R. J., Charbonney, E., Naud, J. F., Roberts, S., Tiruvoipati, R., Gupta, S., Wood, G., Shum, O., Miyakis, S., Dodek, P., Kwok, C., Taggart, L. R., Smith, S. & Doucette, K., Feb 2026, In: Clinical Microbiology and Infection. 32, 3, p. 482-489 8 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
6 Downloads (Pure)
Effect of in vitro synergy and additivity of vancomycin or daptomycin plus an antistaphylococcal β-lactam for methicillin-resistant Staphylococcus aureus bacteraemia on mortality: preplanned analysis from CAMERA2
Soo, J. Z. Y., Lim, T. P., Ho, J. J. Y., Tong, S. Y. C., Lye, D. C., Davis, J. S., Kwa, A. L. H., Yahav, D., Sud, A., Owen Robinson, J., Nelson, J., Archuleta, S., Roberts, M. A., Cass, A., Paterson, D. L., Foo, H., Paul, M., Guy, S. D., Tramontana, A. R. & Walls, G. B. & 27 others, McBride, S., Bak, N., Ghosh, N., Rogers, B. A., Ralph, A. P., Davies, J., Ferguson, P. E., Dotel, R., McKew, G. L., Gray, T. J., Holmes, N. E., Smith, S., Warner, M. S., Kalimuddin, S., Young, B. E., Runnegar, N., Andresen, D. N., Anagnostou, N. A., Johnson, S. A., Chatfield, M. D., Cheng, A. C., Fowler, V. G., Howden, B. P., Meagher, N., Price, D. J., van Hal, S. J. & Sullivan, M. V. N. O., Apr 2026, In: Clinical Microbiology and Infection. 32, 5, p. 829-837 9 p.
Research output: Contribution to journal › Article › peer-review
1 Link opens in a new tab Citation (Scopus)
Management and prevention of lower leg cellulitis: a survey assessing practice variation and equipoise among Australasian clinicians in preparation for a randomised clinical trial
Manning, L., Davis, J. S., Cutfield, T., Hills, T., Meier, C., Ang, S., Hamilton, F., Celenza, A., Raby, E., Hand, R., Cross, E. & Webb, E., Jul 2026, (E-pub ahead of print) In: Internal Medicine Journal. p. 1-7 7 p.
Research output: Contribution to journal › Article › peer-review

File
Accounting for non-adherence to assigned antibiotic treatment duration for bloodstream infection (BALANCE): a post-hoc analysis of a randomised clinical trial
BALANCE trial consortium, Nov 2025, In: The Lancet Infectious Diseases. p. 1-11 11 p.
Research output: Contribution to journal › Article › peer-review

Sepsis in tropical Australia: epidemiology, pathophysiology and adjunctive therapy
Davis, J. (Author), Anstey, N. (Supervisor) & Cheng, A. (Supervisor), Mar 2010
Student thesis: Doctor of Philosophy (PhD) - CDU

File

Combination Antibiotic Therapy for Methicillin Resistant Staphylococcus Aureus infection (CAMERA2)
Davis, J. (Owner), Tong, S. (Creator), Lye, D. (Creator), Paterson, D. (Creator), Nelson, J. (Contributor), Roberts, M. (Creator), Cass, A. (Creator), Yahav, D. (Creator) & Archuleta, S. (Creator), Menzies School of Health Research, 2023
DOI: 10.25913/wjec-8n57, https://www.menzies.edu.au/page/Research/Projects/Staphylococcus/CAMERA_Clinical_Trial_Collection/
Dataset

Joshua Davis

Personal profile

Expertise related to UN Sustainable Development Goals

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

Addressing important evidence gaps in the management of severe infectious diseases

A novel Hepatitis B virus genotype in Indigenous Australians: impact on vaccine efficacy and clinical outcomes

CAMERA: Combination antibiotic treatment for Methicillin Resistant Staphylococcus Aureus Bacteraemia - a Randomised Controlled Trial (CAMERA2)

CAMERA2 - Combination Antibiotic Therapy for Methicillin Resistant Staphylococcus aureus infection. A randomised controlled trial

Determining clinical outcomes associated with different genotypes of Staphylococcus aureus bacteraemia isolates at the Royal Darwin Hospital

Hepatitis B in the Top End of the Northern Territory (NT): health literacy among those affected and innovative ways to improve it.

Improving outcomes of severe bacterial infections in Northern Australia

Application of a Novel Desirability of Outcome Ranking Endpoint Incorporating a Framework for Resistance Assessment and Microbiologic Evaluation in Antibiotic Trials: A Proof-of-Concept in a Post Hoc Analysis of the BALANCE Trial

A review of the randomized clinical trial results from the Staphylococcus aureus network adaptive platform (SNAP) meticillin-susceptible (MSSA) and penicillin-susceptible (PSSA) domains and CloCeBa

Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia

Effect of in vitro synergy and additivity of vancomycin or daptomycin plus an antistaphylococcal β-lactam for methicillin-resistant Staphylococcus aureus bacteraemia on mortality: preplanned analysis from CAMERA2

Management and prevention of lower leg cellulitis: a survey assessing practice variation and equipoise among Australasian clinicians in preparation for a randomised clinical trial

Accounting for non-adherence to assigned antibiotic treatment duration for bloodstream infection (BALANCE): a post-hoc analysis of a randomised clinical trial

Sepsis in tropical Australia: epidemiology, pathophysiology and adjunctive therapy

Combination Antibiotic Therapy for Methicillin Resistant Staphylococcus Aureus infection (CAMERA2)

Joshua Davis

Personal profile

Expertise related to UN Sustainable Development Goals

Fingerprint

Collaborations and top research areas from the last five years

Projects

Research output

Thesis

Datasets